Clinical trial Recruiting at 2 sites Observational

Evaluation of SEBBIN silicone gel-filled testicular implants

Official title: Prospective Observational Study About SEBBIN Silicone Gel-filled Testicular Implants

Run by Groupe SEBBIN · NCT04968470 · Data updated 2026-11-12

This study is testing how safe and effective SEBBIN silicone gel-filled testicular implants are for both adults and children who need them.

Quick facts

Study typeObservational
SexAll
Enrollment100 (estimated)
SponsorGroupe SEBBIN
Industry-sponsored
Locations2 sites (Ghent and 1 other locations)
StatusRecruiting
StartedMarch 16, 2021
Main results expectedSeptember 2025
Study endsSeptember 2035
Registry record updatedOctober 31, 2024
Trial IDNCT04968470 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults or children who are undergoing unilateral or bilateral testicular implant placement with SEBBIN implants.

Probably not a fit

Patients with silicone implants in areas other than the scrotal sac or those with certain autoimmune or inflammatory diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the safety and effectiveness of SEBBIN silicone gel-filled testicular implants. It aims to gather additional data on the durability and complications associated with these implants. Participants include both adults and children who are candidates for unilateral or bilateral testicular implant placement. The study involves collecting information from patients who have received the SEBBIN implant and have provided informed consent.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of the safety and longevity of SEBBIN testicular implants, leading to improved patient outcomes.

How similar studies have gone: While this study focuses on a specific brand of implants, similar studies evaluating the safety and effectiveness of testicular implants have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The patient is an adult or a child at the time of implant placement with SEBBIN implant.
* The patient is candidate to a unilateral or bilateral testicular implant placement with SEBBIN implant.
* The patient has been informed of the study, has read the patient information letter and -provided oral consent.

Exclusion Criteria:

* The patient has silicone implants somewhere else than in the scrotal sac.
* The patient was diagnosed with one of the following pathologies:

  * Systemic lupus erythematous, Sjogren syndrome, scleroderma, polymyositis, or any other connective tissue disease.
  * Rheumatoid arthritis, crystalline arthritis, infectious arthritis, spondyloarthropathies, or any other inflammatory arthritic disease.
  * Arthritis, fibromyalgia, chronic fatigue syndrome, or any other mechanic or degenerative non-inflammatory rheumatic disease.
* The patient has a pathology that could delay healing.
* Custom-designed implants are used for surgery.

Where it's running

  • UZ Gent
    Ghent, Belgium
    Recruiting
  • Centre Hospitalier Lyon Sud
    Pierre-Bénite, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.